You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 9, September 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Vascular Surgery
 •Hepatobiliary Surgery
 •Alert me on articles by topic

Prosthetic Replacement of the Infrahepatic Inferior Vena Cava for Leiomyosarcoma

Giulio Illuminati, MD; Francesco G. Calio’, MD; Antonio D’Urso, MD; Daniela Giacobbi, MD; Vassilios Papaspyropoulos, MD; Gianluca Ceccanei, MD

Arch Surg. 2006;141:919-924.

Hypothesis  Resection of the infrahepatic inferior vena cava associated with prosthetic graft replacement for caval leiomyosarcoma is an acceptable procedure to obtain prolonged and good-quality survival.

Design  A consecutive sample clinical study with a mean follow-up of 40 months.

Setting  The surgical department of an academic tertiary center and an affiliated secondary care center.

Patients  Eleven patients, with a mean age of 51 years, who have primary leiomyosarcoma of the infrahepatic inferior vena cava.

Interventions  All of the patients underwent radical resection of the tumor en bloc with the affected segment of the vena cava. Reconstruction consisted of 10 cavocaval polytetrafluoroethylene grafts and 1 cavobiliac graft. An associated right nephrectomy was performed in 2 cases. The left renal vein was reimplanted in the graft in 3 cases.

Main Outcome Measures  Cumulative disease-specific survival, disease-free survival, and graft patency rates expressed by standard life-table analysis.

Results  No patients died in the postoperative period. The cumulative (SE) disease-specific survival rate was 53% (21%) at 5 years. The cumulative (SE) disease-free survival rate was 44% (19%) at 5 years. The cumulative (SE) graft patency rate was 67% (22%) at 5 years.

Conclusion  Radical resection followed by prosthetic graft reconstruction is a valuable method for treating primary leiomyosarcoma of the infrahepatic inferior vena cava.


Author Affiliations: The "Francesco Durante" Department of Surgery, University of Rome "La Sapienza," Rome (Drs Illuminati, D’Urso, Giacobbi, Papaspyropoulos, and Ceccanei), and the Unit of Vascular Surgery, Sant’Anna Hospital, Catanzaro (Dr Calio’), Italy.


RELATED ARTICLE

Prosthetic Replacement of the Infrahepatic Inferior Vena Cava for Leiomyosarcoma—Invited Critique
William J. Quinones-Baldrich
Arch Surg. 2006;141(9):924.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.